ENB Therapeutics’ Orphan Drug, Endothelin Receptor Type B Target for Resistant Cancers February 15, 2023
2 Women-Founded Companies are Optimizing Targeted Lipid Nanoparticle mRNA Therapies for a Rare Respiratory DiseaseFebruary 3, 2023
All Archives ESG, SRI and Impact Investing: Women as Benefactors and Beneficiaries in RIBy Biotech Metropolitan WomenAugust 31, 2019Responsible Investing (RI) has increasingly become a rule for today’s socially conscience capitalists that want to implement their value set… Read More
